Circio logoCircio logo

  • About
      • About Circio
      • CEO Statement
      • Pipeline
      • Management Team
      • Board of Directors
      • Careers
      • The Norwegian Transparency Act
  • circRNA
      • Circio AB
      • circVec platform
  • Clinical programs
      • KRAS program
      • Publications
  • Partnering
  • Investors
      • Press releases
      • Events
      • Financial calendar
      • Reports
      • Presentations
      • Prospectus
      • Share facts
      • Largest shareholders
      • Dividend policy
      • Analyst coverage
      • Registrar and auditor
      • Corporate Governance Policy
      • Code of Conduct
      • Corporate Social Responsibility Principles
      • Remuneration Principles
      • About General Meeting
        • General Meetings
      • Articles of Association
      • Board of Directors
        • Nomination Committee
        • Committees
      • Management
      • Contact
  • Media
      • Press releases
      • Events
      • Subscribe
      • Contact
  • Contacts
    • About
      • About Circio
      • CEO Statement
      • Our pipeline
      • Management Team
      • Board of Directors
      • Careers
      • The Norwegian Transparency Act
    • circRNA
      • Circio AB
      • circVec platform
    • Clinical programs
      • KRAS program
      • Publications
    • Partnering
      • Partnering
    • Investors
      • Warrants exercise 2024
      • Press releases
      • Events
      • Financial calendar
      • Reports
      • Presentations
      • Prospectus
      • Share information
        • Share and trading information
        • Largest shareholders
        • Dividend policy
        • Analyst coverage
        • Registrar and auditor
      • Corporate Governance Policy
      • Code of Conduct
      • Corporate Social Responsibility Principles
      • Remuneration Principles
      • About General Meeting
      • General Meetings
      • Articles of Association
      • Board of Directors
      • Nomination Committee
      • Committees
      • Management
      • Contact
    • Media
      • Press releases
      • Events
      • Subscribe
      • Contact
    • Contacts
      • Offices
      • Investors & Media

    Other

    All press releases
    • Press releases - Regulatory
    • Press releases - Non-regulatory
    • All press releases
    2018
    • 2022
    • 2019
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    Other
    • All subjects
    • Corporate news
    December 12, 2018
    Press release - Regulatory

    Targovax Presents at DNB 9th Annual Nordic Healthcare Conference

    September 25, 2018
    Press release - Regulatory

    Targovax ASA: Issuance of options to primary insider

    September 12, 2018
    Press release - Regulatory

    Targovax announces publication of new oncolytic virus data in the Journal of Medical Virology and Cancer Gene Therapy

    September 4, 2018
    Press release - Regulatory

    Targovax ASA: Registration of new share capital following settlement of restricted stock units

    August 29, 2018
    Press release - Regulatory

    Targovax ASA: Settlement of restricted stock units and resolution to increase the share capital

    August 15, 2018
    Press release - Regulatory

    Targovax ASA: Invitation to second quarter and first half year 2018 results presentation Thursday 23 August

    June 20, 2018
    Press release - Regulatory

    Targovax ASA: Mandatory notification of trade – primary insider

    June 4, 2018
    Press release - Regulatory

    Targovax to Present at Jefferies 2018 Global Healthcare Conference

    May 16, 2018
    Press release - Regulatory

    Targovax to present at upcoming investor and industry conferences

    April 25, 2018
    Press release - Regulatory

    Targovax ASA: Issuance of restricted stock units (RSUs) to the board members

    April 25, 2018
    Press release - Non-regulatory

    Targovax presentation at ChinaBio Partnering Forum 2018

    April 24, 2018
    Press release - Regulatory

    Targovax ASA: Invitation to first quarter 2018 results presentation Thursday 3 May

    April 11, 2018
    Press release - Regulatory

    Targovax ASA: Protocol from the Annual General Meeting

    March 24, 2018
    Press release - Regulatory

    Targovax ASA: Proposal from the nomination committee to the annual general meeting 11 April 2018

    March 15, 2018
    Press release - Regulatory

    Targovax ASA: Notice of Annual General Meeting

    March 1, 2018
    Press release - Regulatory

    Targovax ASA: Issuance of restricted stock unites (RSUs) to the chairman of the board of directors

    February 27, 2018
    Press release - Non-regulatory

    Targovax to present at Biologics World Nordic 2018

    February 6, 2018
    Press release - Regulatory

    Targovax ASA: Invitation to fourth quarter and full year 2017 results presentation Thursday 15 February

    February 2, 2018
    Press release - Regulatory

    Targovax ASA: Exercise price of options

    February 1, 2018
    Press release - Regulatory

    Targovax ASA issues options to employees

    IR contact
    Dr Erik Digman Wiklund
    Dr Erik Digman Wiklund
    CEO
    erik.wiklund@circio.com
    (+47) 41 33 35 36
    Dr Lubor Gaal
    Dr Lubor Gaal
    CFO & Head of BD
    lubor.gaal@circio.com
    (+34) 683 343 811
    Circio logo

    Circio Holding ASA is a biotechnology company developing novel circular RNA and immunotherapy medicines.

    • About
    • circRNA
    • Clinical programs
    • Partnering
    • Investors
    • Media
    • Contacts

    CONTACT

    Circio Holding ASA
    Email: contact@circio.com

    • Cookies
    • Privacy policy
    • STAY CONNECTED